Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2â advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT
Steger, Guenther G., Egle, Daniel, Bartsch, Rupert, Pfeiler, Georg, Petru, Edgar, Greil, Richard, Helfgott, Ruth, Marth, Christian, Ãhler, Leopold, Hubalek, Michael, Lang, Alois, Tinchon, Christoph,Volume:
50
Language:
english
Journal:
The Breast
DOI:
10.1016/j.breast.2020.01.035
Date:
April, 2020
File:
PDF, 1.28 MB
english, 2020